T Cell Responses to SARS-CoV-2 Infection and Vaccination Are Elevated in B Cell Deficiency and Reduce Risk of Severe COVID-19

Scientists evaluated the cellular immune responses after both SARS-CoV-2 infection and vaccination in patients receiving the anti-CD20 therapy rituximab and those with low B cell counts due to common variable immune deficiency disease.